Stocksigma LogoStocksigma Logo

Counter Cyclical Investments Increases Stake in Jenburkt Pharmaceuticals to 5.11%

Counter Cyclical Investments Private Limited (PMS), along with its clients (PAC), acquired 4,608 equity shares (0.10% stake) of Jenburkt Pharmaceuticals

Counter Cyclical Investments Increases Stake in Jenburkt Pharmaceuticals to 5.11%

Jenburkt Pharmaceuticals Ltd 路 Acquisition/ Disposal of Shares 路 04 Nov 2026, 9:20 pm

Counter Cyclical Investments Increases Stake in Jenburkt Pharmaceuticals to 5.11% Counter Cyclical Investments Private Limited (PMS), along with its clients (PAC), acquired 4,608 equity shares (0.10% stake) of Jenburkt Pharmaceuticals Ltd via open market purchases on 3rd Nov'26. Following the transaction, the non-promoter entity's total holding in the target company increased from 220,931 shares (5.01%) to 225,539 shares, representing 5.11% of the total voting and diluted share capital comprising 4,413,300 equity shares.

Original exchange filing (PDF)

More announcements from Jenburkt Pharmaceuticals Ltd

All Jenburkt Pharmaceuticals Ltd announcements